Short answer
Ingevity Corp (NGVT) filed its Q1 2026 10-Q quarterly report on May 7, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $258M (down 9.2% year over year) with net income of $60M.
Q1 2026 key financials · XBRL
- Revenue
- $258M
- −9.2% YoY
- Net income
- $60M
- +191.7% YoY
- Gross margin
- 45.1%
- EPS (diluted)
- $1.66
- +196.4% YoY
Source: XBRL data from the Ingevity Corp (NGVT) Q1 2026 10-Q on SEC EDGAR. USD.
Ingevity Corp Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Results-of-operations discussion provided without quarterly financial results
- No profitability, margin, segment, cash-flow, or capital-deployment figures disclosed
Risk Factors
- Newly added risk: intellectual-property litigation, including potential infringement damages or product injunctions
- Regulatory/legal risk: patent challenges, invalidation, or third-party claims could require substantial damages
- Operational risk: China manufacturing increases exposure to proprietary-technology misappropriation
- Competitive risk: loss of trade-secret protection could reduce revenues, margins, or market share
- Financial risk: $245.6 million remaining under the stock-repurchase authorization after $774,189 shares purchased
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Ingevity Corp quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.